Application 208645
- Type
- NDA
- Sponsor
- ACTAVIS LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BORTEZOMIB | BORTEZOMIB | INJECTABLE; INJECTION | 2.5MG/ML | No | No |
| 002 | BORTEZOMIB | BORTEZOMIB | INJECTABLE; INJECTION | 3.5MG/1.4ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bortezomib | BORTEZOMIB | Sintetica US LLC | d79a71ec-b46d-4961-ad05-8980915cba94 | 2023-10-09 | Warnings, Adverse reactions | Bortezomib BORTEZOMIB |
| BORTEZOMIB | BORTEZOMIB | Hospira, Inc. | 9fdf6169-699f-40eb-bda1-760253062b3c | 2023-02-27 | Warnings, Adverse reactions | BORTEZOMIB BORTEZOMIB |
| Bortezomib | BORTEZOMIB | Novadoz Pharmaceuticals LLC | d41340c2-7fe8-42b2-aaa5-c9f9b0e9b50e | 2022-07-20 | Warnings, Adverse reactions | Bortezomib BORTEZOMIB |
| Bortezomib | BORTEZOMIB | BluePoint Laboratories | 12500f21-8e2f-4bcd-861e-4dfca843da2e | 2022-05-16 | Warnings, Adverse reactions | Bortezomib BORTEZOMIB |
| Bortezomib | BORTEZOMIB | Qilu Pharmaceutical Co., Ltd. | aef02171-bf8a-43ad-b40c-7642623f9802 | 2022-05-09 | Warnings, Adverse reactions | Bortezomib BORTEZOMIB |
| BORTEZOMIB | BORTEZOMIB | Zydus Lifesciences Limited | 582c7c0d-fa25-4586-8157-a1e2653d72d9 | 2022-05-05 | BORTEZOMIB BORTEZOMIB | |
| Bortezomib | BORTEZOMIB | Pharmascience Inc. | 191d231a-1fbd-4a65-9d33-d5dc03bac381 | 2022-05-02 | Warnings, Adverse reactions | Bortezomib BORTEZOMIB |
| Bortezomib | BORTEZOMIB | Waverley Pharma Inc | a73d7ea7-d068-4d25-b368-fc3db1898be2 | 2022-04-13 | Warnings, Adverse reactions | Bortezomib BORTEZOMIB |
| bortezomib | BORTEZOMIB | Hikma Pharmaceuticals USA Inc. | 854be921-5fd9-482a-8432-a0c0241625f8 | 2021-11-22 | Warnings, Adverse reactions | bortezomib BORTEZOMIB |
| Bortezomib | BORTEZOMIB | MAIA Pharmaceuticals, Inc. | c40e6a28-d577-43d4-bca6-bef28da1d580 | 2021-09-22 | Warnings, Adverse reactions | Bortezomib BORTEZOMIB |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 45630 | ORIG | 2016-10-21 |